首页> 外文期刊>Pathobiology: journal of immunopathology, molecular and cellular biology >Polo-like kinase 1 expression in medullary carcinoma of the thyroid: its relationship with clinicopathological features.
【24h】

Polo-like kinase 1 expression in medullary carcinoma of the thyroid: its relationship with clinicopathological features.

机译:Polo样激酶1在甲状腺髓样癌中的表达:与临床病理特征的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Polo-like kinase 1 (PLK1) is one of the serine-threonine kinases that contributes to cell mitosis and is regarded as a marker of cellular proliferation. However, its protein expression in human carcinoma has not been studied in depth. In this study, we investigated PLK1 expression in medullary thyroid carcinoma by means of immunohistochemistry. METHODS: We immunohistochemically investigated PLK1 expression in 67 cases of medullary thyroid carcinoma. RESULTS: The PLK1 expression level was elevated in 43 of the 67 cases (64.1%). Furthermore, the expression level was directly linked to lymph node metastasis, advanced stage and male sex. All patients who were negative for PLK1 expression are currently alive without tumor recurrence, while 6 of the 43 PLK1-positive patients showed recurrence and 3 have already died of this disease. CONCLUSIONS: These findings suggest that PLK1 expression significantly reflects aggressive characteristics of medullary thyroid carcinoma.
机译:目的:马球样激酶1(PLK1)是一种丝氨酸-苏氨酸激酶,可导致细胞有丝分裂,并被视为细胞增殖的标志。然而,尚未深入研究其在人癌中的蛋白表达。在这项研究中,我们通过免疫组织化学研究了甲状腺髓样癌中PLK1的表达。方法:我们用免疫组织化学方法检测了67例甲状腺髓样癌中PLK1的表达。结果:67例患者中43例的PLK1表达水平升高(64.1%)。此外,表达水平与淋巴结转移,晚期和男性直接相关。目前所有PLK1表达阴性的患者都活着,没有肿瘤复发,而43名PLK1阳性患者中有6例复发,其中3例已经死亡。结论:这些发现表明PLK1表达明显反映甲状腺髓样癌的侵袭性特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号